Silicon Valley Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.8K Buy
380
+30
+9% +$3.46K ﹤0.01% 150
2025
Q4
$36.9K Sell
350
-72
-17% -$6.76K ﹤0.01% 153
2025
Q3
$35.4K Buy
422
+260
+160% +$21.4K ﹤0.01% 150
2025
Q2
$12.8K Buy
162
+53
+49% +$4.21K ﹤0.01% 194
2025
Q1
$9.72K Sell
109
-24
-18% -$2.24K ﹤0.01% 202
2024
Q4
$13.2K Sell
133
-72,202
-100% -$7.44M ﹤0.01% 236
2024
Q3
$8.21M Buy
72,335
+8,982
+14% +$1.07M 1.07% 29
2024
Q2
$7.84M Buy
63,353
+3,451
+6% +$445K 1.08% 30
2024
Q1
$7.9M Buy
59,902
+9,652
+19% +$1.19M 1.18% 25
2023
Q4
$5.48M Buy
50,250
+4,400
+10% +$457K 0.92% 29
2023
Q3
$4.72M Buy
45,850
+15,011
+49% +$1.62M 0.89% 31
2023
Q2
$3.56M Buy
30,839
+3,646
+13% +$414K 0.66% 29
2023
Q1
$2.89M Buy
27,193
+1,675
+7% +$181K 0.61% 29
2022
Q4
$2.83M Buy
+25,518
New +$2.61M 0.65% 24

Other funds holding MRK

Silicon Valley Capital Partners's MRK Position: Q1 2026 in Review

Silicon Valley Capital Partners increased its Merck (MRK) stake by 8.6% in Q1 2026, buying an estimated $3.46K and bringing the position to 380 shares worth $45.8K. The position accounts for ﹤0.01% of the portfolio, ranked #150.

Silicon Valley Capital Partners first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $8.21M in Q3 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Silicon Valley Capital Partners held 380 shares of Merck worth $45.8K as of Q1 2026.
  • Silicon Valley Capital Partners bought 30 Merck shares in Q1 2026, an estimated $3.46K.
  • Merck made up ﹤0.01% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #150 holding.
  • Silicon Valley Capital Partners first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Silicon Valley Capital Partners's Merck position peaked at $8.21M in Q3 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.